Journals / The anatolian journal of family medicine (Online) / 2020 / Cilt: 3 - Sayı: 3

Are Patients Diagnosed with Chronic Hepatitis B Aware of Their Disease?

Pages
242–248
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increasing awareness of patients about their diseases will decrease the spread of infection and controlthe complications that may arise in the future due to hepatitis B.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to determine the level of knowledge of patients being followed up with a diagnosis of chronic hepatitis B Infection about the disease, route of transmission, prevention and treatment.Methods: A cross-sectional survey was conducted between June-December 2016.
📊
Key Findings & Data:The survey consisted ofquestions about demographic information, general information about the disease, routes of transmission, prevention, treatment and patient follow-up.Results: The questionnaire was administered to 500 patients.
💡
Conclusion & Impact:Increasing awareness of patients about their diseases will decrease the spread of infection and controlthe complications that may arise in the future due to hepatitis B.
🔬Design:Survey & Empirical Study
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to determine the level of knowledge of patients being followed up with a diagnosis of chronic hepatitis B Infection about the disease, route of transmission, prevention and treatment.Methods: A cross-sectional survey was conducted between June-December 2016. The survey consisted ofquestions about demographic information, general information about the disease, routes of transmission, prevention, treatment and patient follow-up.Results: The questionnaire was administered to 500 patients. The mean age of the patients was 42.2±12.9years, 319 (63.8%) were male. In this study, 141 (28.2%) of the patients said that hepatitis B was not an infectious disease. The level of knowledge about the name of the disease, infectiousness and its complications wassignificantly high in patients with a high education level and in patients who were diagnosed with hepatitis Bfor more than five years. While 214 (98.7%) patients with high education level knew the name of the diseaseand 191 (88.0%) patients knew virus’ infectiousness and its complications. Three hundred twenty-one (97.6%)patients with hepatitis B for more than five years knew the name of the disease and 278 (84.5%) patients knewthe virus' infectiousness and its complications.Conclusion: Hepatitis B infection stil remains a critical health problem for both the patient and his environment. Increasing awareness of patients about their diseases will decrease the spread of infection and controlthe complications that may arise in the future due to hepatitis B.

🔖

Cite This Article

ERGEN, P., KARADAĞ, F. Y., AYDIN, Ö., DOĞRU, A., ÜÇIŞIK, A. C., YAZICI, S., SAĞLAM, Z. A., VAHABOĞLU, M. H. (2020). Are Patients Diagnosed with Chronic Hepatitis B Aware of Their Disease?. The anatolian journal of family medicine (Online), Cilt: 3 - Sayı: 3, 242–248. https://ajindex.com/articles/365018

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004 Mar;11(2):97-107
  2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005 Dec;34(6):1329-39
  3. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012 Mar 9;30(12):2212-9
  4. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol. 2000 Jul;61(3):362-6
  5. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015 Oct 17;386(10003):1546-55
  6. Toy M, Önder FO, Wörmann T, Bozdayi AM, Schalm SW, Borsboom GJ, van Rosmalen J, Richardus JH, Yurdaydin C. Ageand region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011 Dec 12;11:337
  7. Ay P, Torunoğlu MA, Com S, Çipil Z, Mollahaliloğlu S, Erkoç Y, et al. Trends of hepatitis B notification rates in Turkey, 1990 to 2012 separator commenting unavailable. Euro Surveill 2013;18(47):pii=20636
  8. Gürakar M, Malik M, Keskin O, Idilman R. Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy. Turk J Gastroenterol. 2014 Jun;25(3):304-8. 9. ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Haseeb A et al. A cross-sectional assessment of knowledge, attitude and practice among Hepatitis-B patients in Quetta, Pakistan. BMC Public Health 2013;13:448
  9. Tamayo A, Shah SR, Bhatia S, Chowdhury A, Rao PN, Dinh P, Knox SJ, Gaggar A, Subramanian GM, Mohan VG, Sood A, Mehta R, Sarin SK. Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India. Hepatol Int. 2016 Nov;10(6):988-995
  10. Türkiye Viral Hepatit Önleme ve Kontrol Programı, Sağlık Bakanlığı Yayın No: 1102, Ankara, 2018. Available at: https:// hsgm.saglik.gov.tr/depo/birimler/Bulasici-hastaliklar-db/ duyurular/Turkiye_Viral_Hepatit_Onleme_ve_Kontrol_Programi/Turkiye_Viral_Hepatit_Onleme_ve_Kontrol_Programi_ TR.pdf. Accessed Oct 30, 2020
  11. Ganczak M, Dmytrzyk-Daniłów G, Korzeń M, Drozd-Dąbrowska M, Szych Z. Prevalence of H